Recent Articles
Merck Stock Remains a Dull Biotech Play Despite Earnings Success
MRK stock isn't bad. It has a reasonable valuation, okay growth and a solid dividend. But Merck isn't my favorite pick in biotech.
Blowout Earnings Should Add to the Rally in Activision Blizzard Stock
ATVI stock dipped after earnings, but the stock is just taking a breather. User growth and a big guidance hike underpin a strong long-term case.
Soaring Southwest Airlines Stock Will Stay Sector Leader
Southwest Airlines has a strong balance sheet and rebounding revenue. As a result, LUV stock should be a top industry pick.
Stay Far Away From ‘Sucker’s Bet’ Kodak Stock
The latest scheme to breathe life into Kodak stock won't end well for investors. Speculation will fizzle out, so avoid it completely.
The Breakout Rally In Advanced Micro Devices Stock Is Far From Over
After doubling from the lows, AMD stock might seem to need a breather. But a secular growth story and a competitive edge suggest more upside ahead.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
